Cholecystokinin octapeptide (CCK-8) concentration in plasma is not affected in functional abdominal pain in children

M Uścinowicz1, M Kaczmarski

  • 1III Department of Paediatrics, Medical University of Białystok, Poland. mirusc@o2.pl

Insights

Plasma cholecystokinin octapeptide (CCK-8) levels do not appear to be a reliable diagnostic marker for functional abdominal pain (FAP) in children, including irritable bowel syndrome (IBS) and functional dyspepsia (FD). Further research is needed to understand FAP in pediatric populations.

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Physiology
  • Biomarker Discovery

Background:

  • Cholecystokinin (CCK) plays a crucial role in regulating gastrointestinal motility and visceral sensation.
  • Functional abdominal pain (FAP) is a common condition in children, characterized by recurrent abdominal pain without an identifiable organic cause.
  • Understanding the physiological underpinnings of FAP is essential for developing effective diagnostic tools and treatments.

Purpose of the Study:

  • To investigate the diagnostic value of plasma cholecystokinin octapeptide (CCK-8) concentration in children diagnosed with functional abdominal pain (FAP).
  • To compare CCK-8 levels in children with different subtypes of FAP (functional dyspepsia, irritable bowel syndrome, non-specific FAP) and healthy controls.

Main Methods:

  • A study involving 52 children (aged 6-17) with chronic abdominal pain, categorized into functional dyspepsia (FD), irritable bowel syndrome (IBS), and non-specific FAP groups.
  • Plasma CCK-8 concentrations were measured using radioimmunoassay in a fasting state and at 15, 30, and 60 minutes after a standard test meal.
  • A control group of children without a history of abdominal pain was included for comparison.

Main Results:

  • Fasting plasma CCK-8 levels were comparable across all patient groups and the control group.
  • Postprandial CCK-8 levels increased significantly in functional dyspepsia, non-specific FAP, and control groups, but not in the irritable bowel syndrome group.
  • The area under the curve for CCK-8 plasma concentration was lowest in the IBS group, though not statistically significant compared to other groups.

Conclusions:

  • Plasma CCK-8 levels, both fasting and postprandial, do not appear to be significantly altered in children with functional abdominal pain, including IBS and FD.
  • The findings suggest that alterations in plasma CCK-8 are unlikely to be the primary cause of gut dysmotility or symptoms associated with FAP in pediatric populations.
  • CCK-8 is not a reliable diagnostic biomarker for FAP in children based on this study.
Abstract

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Intestinal Phase of Digestion01:29

Intestinal Phase of Digestion

The intestinal phase of digestion is the third and final stage of the digestive process, occurring after the cephalic and gastric phases. It begins when chyme, a partially digested mixture of food and digestive enzymes, enters the small intestine from the stomach. This phase is crucial for nutrient absorption and involves complex hormonal and enzymatic interactions.
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...
Hormonal Regulation01:40

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...